Pilot study on the probability of drug-drug interactions among direct oral anticoagulants (DOACs) and antiseizure medications (ASMs): a clinical perspective.

Federica RanzatoRoberta RobertiCristina DelucaMariarosa CartaAlessia PerettiDiana PoloFrancesco PeriniEmilio RussoGianfranco Di Gennaro

Published in: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2023)

These preliminary results confirm the reduction of DOAC's PC by I-ASMs and suggest a better manageability of apixaban, dabigatran, and edoxaban independently from the concomitant ASM, whereas rivaroxaban seems the most liable to PC alterations with I-ASMs.

Keyphrases

direct oral anticoagulants
venous thromboembolism
atrial fibrillation
emergency department